Med-X

Growth Stage

Making a Difference, Naturally.

Analytics

Raised to Date: Raised: $3,953,042

Aggregate Commitments $

Platform

Dalmore Group

Start Date

07/23/2021

Close Date

06/30/2022

Min. Goal

$420

Max. Goal

$10,000,000

Min. Investment

$420

Security Type

Equity - Common

Funding Type

RegA+

Series

Series A

Price Per Share

$0.80

Pre-Money Valuation

$102,217,405

Rolling Commitments $

Status

Active

Reporting Date

05/27/2022

Days Remaining

34

% of Min. Goal

941,201%

% of Max. Goal

40%

Likelihood of Max
unlikely
Avg. Daily Raise

$12,835

Momentum
cold.svg
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Canoga Park, California

Industry

Consumer Products, Goods & Services

Tech Sector

Cleantech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

Med-X, with a pre-money valuation of $102 million, is raising funds on Dalmore via Regulation A+. The company has developed many all-natural and plant-based brands that are replacing chemicals to solve everyday issues. The products are sold through major retail and healthcare distributors. The flagship product lines of Med-X include Nature-Cide and Thermal-Aid. Med-X is led by Dr. David Toomey and Matthew Mills and was founded in 2014.

Balance Sheet

Cash and Cash Equivalents

$752,823

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$150,929

Loans

$0

Property, Plant and Equipment (PP&E)

$81,971

Property and Equipment

$0

Total Assets

$3,081,150

Accounts Payable & Accrued Liabilities

$352,317

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$1,156,573

Total Liabilities

$2,194,674

Total Stockholders' Equity

$886,476

Total Liabilities and Equity

$3,081,150

Statement of Comprehensive Income Information

Total Revenues

$1,033,750

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$711,820

Total Interest Expenses

$0

Depreciation and Amortization

$115,398

Net Income

$-3,050,009

Earnings Per Share - Basic

$0

Earnings Per Share - Diluted

$0

Auditor: Prager Metis, CPA's LLP
Financials as of: 07/23/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Med-X 06/30/2022 Dalmore Group $102,217,405 $3,953,042 Equity - Common Active RegA+
Med-X 09/10/2021 TruCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
Med-X 06/27/2019 StartEngine - $0 Equity - Common Funded RegA+
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Med-X on Dalmore Group 2021
$
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $102,217,405
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Med-X on Dalmore Group 2021
View on Dalmore Group
Bullish / Bearish
You're Bullish on Med-X on Dalmore Group 2021

Thank you for your vote on Med-X on Dalmore Group 2021

Bullish / Bearish
You're Bearish on Med-X on Dalmore Group 2021

Thank you for your vote on Med-X on Dalmore Group 2021